News Pfizer looks to confirm US licence for breast cancer pill Pfizer has filed late stage data with FDA.
News Roche to file Actemra in inflamed artery disease Drug successful in late stage trial for giant cell arteritis
News Novartis drug gets fast US review in AML Midostaurin also under review in rare disease systemic mastocytosis
News Expert questions survival benefit of cancer drugs Spending vast sums to extend life by weeks or months may be unethical, says doctor.
News US advisers back Cempra pneumonia antibiotic But panel of FDA advisers concerned over liver safety.
News Novartis' LEE011 on fast track to challenge Ibrance US regulator grants fast review for breast cancer drug.
News GSK to quit Stevenage for new R&D site in Cambridge In a major shake-up of its UK operations, GSK is building a brand new R&D centre in Cambridge and transfer operations there from its Stevenage campus.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.